Dallah Healthcare Company (TADAWUL:4004)

Saudi Arabia · Delayed Price · Currency is SAR

100.60

+1.90 (1.93%)

Mar 3, 2026, 3:17 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Distribution of Pharmaceutical Products	151.94M	133.40M	120.08M	138.29M	-
Distribution of Pharmaceutical Products Growth	13.89%	11.10%	-13.17%	-	-
Medical Facilities and Pharmacies	3.05B	2.81B	2.37B	1.97B	-
Medical Facilities and Pharmacies Growth	8.70%	18.65%	20.39%	-	-
Total	3.21B	2.94B	2.49B	2.11B	-
Total Growth	8.93%	18.28%	18.18%	-	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Kingdom of Saudi Arabia	3.21B	2.94B	2.49B	2.11B	1.32B
Kingdom of Saudi Arabia Growth	8.93%	18.28%	18.18%	59.69%	5.28%
Total	3.21B	2.94B	2.49B	2.11B	1.32B
Total Growth	8.93%	18.28%	18.18%	59.69%	5.28%

Source: S&P Global Market Intelligence.